Ind-Swift Laboratories Ltd

Ind-Swift Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Ind-Swift Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 16 July 2026, providing investors with the latest insights into the company’s performance and outlook.

Surging past its previous peak, Ind-Swift Laboratories Ltd touched a new 52-week high of Rs 248 on 13 Jul 2026, marking a remarkable 130.48% gain over the past year. This milestone comes amid a backdrop of strong technical momentum that has propelled the stock well beyond its 52-week low of Rs 87, even as the broader Sensex trades lower by 6.59% over the same period.

Ind-Swift Laboratories Ltd, a key player in the Pharmaceuticals & Biotechnology sector, achieved a significant milestone on 13 July 2026 by reaching its all-time high price of Rs.248. This landmark reflects the company’s sustained upward trajectory over recent years and highlights its notable market performance amid sectoral trends.

Surging past its previous peak, Ind-Swift Laboratories Ltd touched a fresh 52-week high of Rs 241 on 10 Jul 2026, marking a remarkable rally that has more than doubled its share price from Rs 87 over the past year.

Ind-Swift Laboratories Ltd has reached a significant milestone by touching an all-time high price of Rs.241 on 10 July 2026, reflecting a robust performance trajectory and sustained investor confidence in the pharmaceuticals and biotechnology sector.

Extending its remarkable rally, Ind-Swift Laboratories Ltd surged to a fresh all-time high of Rs 234.9 on 08 Jul 2026, outperforming the Sensex by a wide margin and marking a significant milestone in its price journey.

Surging past its previous peaks, Ind-Swift Laboratories Ltd touched a fresh 52-week high of Rs 234.9 on 8 Jul 2026, marking a remarkable 94.62% gain over the past year. This milestone comes amid a backdrop of strong technical momentum, even as the broader Sensex trades lower by 0.74% on the day.

Surging past its previous peaks, Ind-Swift Laboratories Ltd touched a fresh 52-week high of Rs 223.45 on 6 Jul 2026, marking a remarkable rally from its 52-week low of Rs 87. This milestone caps a sustained uptrend fuelled by a confluence of bullish technical indicators and robust price momentum.

Ind-Swift Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 July 2026, providing investors with the most recent insights into the company’s performance and outlook.

From a 52-week low of Rs 87 to a fresh high of Rs 213.8 on 3 Jul 2026, Ind-Swift Laboratories Ltd has surged 87.3% in the past year, significantly outpacing the Sensex’s decline of 6.2%. This milestone caps a period of strong momentum fuelled by a confluence of bullish technical indicators and sustained price strength.

With a surge to Rs 207.6 on 29 Jun 2026, Ind-Swift Laboratories Ltd has reached a fresh 52-week high, marking an impressive 89.8% gain over the past year. This milestone comes amid a backdrop of strong technical momentum and sustained price strength, setting the stock apart in the Pharmaceuticals & Biotechnology sector.

With a remarkable 86.57% gain over the past year, Ind-Swift Laboratories Ltd has surged to a fresh 52-week high, touching an intraday peak of Rs 200.4 on 25 Jun 2026. This milestone comes amid a broader market rally, with the Sensex advancing 0.72% and trading near its own recent highs.

Ind-Swift Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 June 2026, providing investors with the latest insights into the company’s performance and outlook.

Surging past its previous peaks, Ind-Swift Laboratories Ltd touched a new 52-week high of Rs 198.9 on 23 Jun 2026, marking a remarkable 128% rise from its 52-week low of Rs 87. This milestone caps a sustained rally fuelled by a confluence of bullish technical indicators and robust price momentum.

From a 52-week low of Rs 87 to a fresh high of Rs 197, Ind-Swift Laboratories Ltd has surged by over 81% in the past year, outpacing the Sensex which declined 6.4% over the same period. This remarkable price momentum culminated in the stock hitting a new 52-week peak on 22 Jun 2026, driven by a confluence of bullish technical signals and sustained buying interest.

With a decisive surge to Rs 178.65 on 19 Jun 2026, Ind-Swift Laboratories Ltd has reached a fresh 52-week high, marking a remarkable 75.53% gain over the past year. This milestone comes amid a backdrop of strong technical momentum that has propelled the stock well above its key moving averages, even as the broader Sensex trades lower.